Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OraVerse for Reversing Local Anesthesia in Children
NCT05448807Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of phentolamine in soft tissue injury (2 arms), sponsored by Cairo University. Primary endpoint: Time to return to normal function at 2 hours. Started Jul 2025; status: recruiting.
02
Drugs
phentolamine
03
Conditions
soft tissue injury
Beyond the preview
Go deeper on NCT05448807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05448807.